Los Angeles, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Ovation^® Fertility is once again proving its status as a prolific producer of research in the field of reproductive medicine, with six abstracts accepted for poster presentations at the ASRM 2020 Scientific Congress and Expo, the premier conference for reproductive experts, taking place October 17-21, 2020. Additionally, Ovation scientists are leading several interactive sessions and roundtable discussions at the virtual event.

“Ovation is once again honored to get to participate in ASRM and play a leading role in advancing the state of the art in IVF,” says Matthew “Tex” VerMilyea, PhD, HCLD/CC, vice president of scientific advancement. “This year’s ASRM Congress is taking place online for obvious reasons, but the global pandemic has not stopped Ovation scientists from collaborating on their ongoing research while supporting physicians and patients across our network of nine nationwide IVF labs. We are eager to share our findings with other IVF researchers and fertility specialists, so that more hopeful parents can benefit from the latest scientific advances to grow their families.”

The list of Ovation abstracts and presentations accepted for ASRM 2020 covers a wide range of topics of importance to IVF scientists worldwide.

Presentations and Sessions:

• CME Interactive Session: Benefits and Limitations of Time Lapse Imaging and AI in ART. T. Arthur Chang, PhD, HCLD, ELD, (Chair) University of Texas Health Science Center; Eva Schenkman, MS, CCRM; Matthew David VerMilyea, Ph.D., Ovation Fertility.
• RD2-18 Roundtable Discussion: PGT Technologies: How to Know What Is Safe and Effective for Your Patients. Amy Jones, MS, Ovation Fertility.
• RD5-10 IVF Roundtable Discussion: Add-ons: Patient Driven or Financially Motivated. Matthew VerMilyea, PhD, Ovation Fertility.

Poster Presentations:

• P-46: Stage of Transferred Blastocyst May Affect Pregnancy Outcomes When Timed with Endometrial Receptivity Assay (ERA). Rae vanTol, BS¹; Robert Colver, MD²; Bradford Bopp, MD²; Matthew Will, MD²; Erica Anspach Will, MD²; Glen Adaniya, PhD¹. ¹Ovation Fertility, Indianapolis, Indiana; ²Midwest Fertility Specialists, Carmel, Indiana.
• P-92: Evidence for Superior Blastocyst Cohort Ranking Using Artificial Intelligence Based on Retrospective Clinical Pregnancy Results. Matthew David VerMilyea, PhD¹; Milad A Dakka, PhD²; Jonathan MM Hall, PhD³; Sonya M Diakiw, PhD²; Tuc Van Nguyen, PhD²; Don Perugini, PhD²; Kaylen Silverberg, MD⁴; Michelle Perugini, PhD². ¹Ovation Fertility, San Antonio, Texas; ²Presagen and Life Whisperer, Adelaide, SA, Australia; ³Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Adelaide, SA, Australia.
• P-100: Identifying Inherent Poor Quality Embryo Data Using Artificial Intelligence to Improve AI Performance and Clinical Reporting. Milad A Dakka, PhD¹; Matthew David VerMilyea, PhD²; Tuc Van Nguyen, PhD¹; Don Perugini, PhD¹; Sonya M Diakiw, PhD¹; Kaylen Silverberg, MD³; Jonathan MM Hall, PhD⁴; Michelle Perugini, PhD¹. ¹Presagen and Life Whisperer, Adelaide, SA, Australia; ²Ovation Fertility, San Antonio, Texas;  ³Texas Fertility Center, Austin, Texas; ⁴Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Adelaide, SA, Australia.
• P-135: Alternative Blastocyst Vitrification Warming-Dilution Approaches: Do Virtues of the Kiss Principle Apply? Mitchel C. Schiewe, PhD, HCLD (ABB)¹; Tannia Ochoa, BA¹; Casey Zeffiro, BA, BS, MS¹; Shane Zozula, BS, TS (ABB)¹; James Stachecki, PhD². ¹Ovation Fertility, Newport Beach, California; ²Innovative Cryo Enterprises LLC, Linden, New Jersey.
• P-190: Status Quo – Or Is It Time to Reconsider the Vitrification Method Relative to the Risk of Embryo Disease Transmission in Cryostorage? Mitchel C. Schiewe, PhD, HCLD (ABB)¹; Shane Zozula, BS, TS (ABB)¹; Nancy L. Nugent, MS¹; James Stachecki, PhD²; Robert E. Anderson, MD³. ¹Ovation Fertility, Newport Beach, California; ²Innovative Cryo Enterprises LLC, Linden, New Jersey; ³SCCRM, Newport Beach, California.
• P-456: The Degree of Blastocyst Expansion Post-Warming Strongly Predicts Clinical Outcomes in Single Frozen Embryo Transfer Cycles (SFET). Ahmad Morsi Abu Maizar, MSc¹; Diane Wright, PhD²; Richard Marrs, MD¹; Guy E Ringler, MD¹; Kelly J Baek, MD¹; Karine Chung, MD¹; Matthew David VerMilyea, PhD³.  ¹California Fertility Partners, Los Angeles, California; ²Ovation Fertility, Houston, Texas; ³Ovation Fertility, San Antonio, Texas.

Ovation research presented at ASRM 2020 will be available at www.OvationFertility.com/research.

About Ovation Fertility

Ovation^® Fertility is a national network of reproductive endocrinologists and scientific thought leaders focused on reducing the cost of having a family through more efficient and effective fertility care. Ovation’s IVF and genetics laboratories, along with affiliated physician practices, work collaboratively to raise the bar for IVF treatment, with state-of-the-art, evidence-based fertility services that give hopeful parents the best chance for a successful pregnancy. Physicians partner with Ovation to offer their patients advanced preconception carrier screening; preimplantation genetic testing; donor egg and surrogacy services; and secure storage for their frozen eggs, embryos and sperm. Ovation also helps IVF labs across America improve their quality and performance with expert off-site lab direction and consultation. Learn more about Ovation’s vision of a world without infertility at www.OvationFertility.com.

Attachment

• Matthew VerMilyea

Amy Hall
Ovation Fertility 
214.893.8214
AHall@OvationFertility.com